Filing Details
- Accession Number:
- 0001179110-15-014505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-04 17:14:06
- Reporting Period:
- 2015-11-02
- Filing Date:
- 2015-11-04
- Accepted Time:
- 2015-11-04 17:14:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1638474 | W. Jeffrey Albers | C/O Blueprint Medicines Corporation 38 Sidney Street, Suite 200 Cambridge MA 02139 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-02 | 10,000 | $21.02 | 133,486 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.